RecruitingPhase 2NCT02939573
A Randomized Multicenter Study for Isolated Skin Vasculitis
Studying Cutaneous polyarteritis nodosa
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Pennsylvania
- Principal Investigator
- Robert Micheletti, MDUniversity of Pennsylvania
- Intervention
- Colchicine(drug)
- Enrollment
- 90 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2028
Study locations (16)
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Boston University School of Medicine, Boston, Massachusetts, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Northwell Health, Lake Success, New York, United States
- Hospital for Special Surgery, New York, New York, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- Penn State Hershey Medical Center, Hershey, Pennsylvania, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- Vanderbilt University, Nashville, Tennessee, United States
- UT Southwestern Medical Center, Dallas, Texas, United States
- University of Utah, Salt Lake City, Utah, United States
- University of Virginia, Charlottesville, Virginia, United States
- St. Joseph's Healthcare, Hamilton, Ontario, Canada
- University of Toronto Mount Sinai Hospital, Toronto, Ontario, Canada
- McGill University Health Centre, Montreal, Quebec, Canada
- +1 more locations on ClinicalTrials.gov
Collaborators
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · National Center for Advancing Translational Sciences (NCATS) · Office of Rare Diseases (ORD)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02939573 on ClinicalTrials.gov